Compounded Bioidentical Hormone Therapy Market

Bioidentical hormones are artificial hormones that are chemically similar to those naturallyproduced by the human body. Because they are chemically similar to the hormones produced by the body, bioidentical hormones act as the body's own hormones with very few side effects.
Compounded Bioidentical Hormone Therapy Market contains market size and forecasts of Compounded Bioidentical Hormone Therapy in global, including the following market information:
Global Compounded Bioidentical Hormone Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Compounded Bioidentical Hormone Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Compounded Bioidentical Hormone Therapy companies in 2021 (%)
The global Compounded Bioidentical Hormone Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oestrogen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Compounded Bioidentical Hormone Therapy include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Compounded Bioidentical Hormone Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Compounded Bioidentical Hormone Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Type, 2021 (%)
Oestrogen
Progesterone
Testosterone
Global Compounded Bioidentical Hormone Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Compounded Bioidentical Hormone Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Compounded Bioidentical Hormone Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Compounded Bioidentical Hormone Therapy revenues share in global market, 2021 (%)
Key companies Compounded Bioidentical Hormone Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Compounded Bioidentical Hormone Therapy sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Bio station
Noven Pharmaceuticals
Novartis AG
Pfizer
TherapeuticsMD
Bayer AG
Novo Nordisk